{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:16:05Z","timestamp":1776435365968,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s12264-007-0051-9","type":"journal-article","created":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T23:55:16Z","timestamp":1201910116000},"page":"341-347","source":"Crossref","is-referenced-by-count":31,"title":["No changes in densities of cannabinoid receptors in the superior temporal gyrus in schizophrenia","\u7cbe\u795e\u5206\u88c2\u75c7\u60a3\u8005\u989e\u4e0a\u56de\u7684\u5927\u9ebb\u7d20\u53d7\u4f53\u5bc6\u5ea6\u6ca1\u6709\u663e\u8457\u6027\u53d8\u5316"],"prefix":"10.1007","volume":"23","author":[{"given":"Chao","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,3]]},"reference":[{"key":"51_CR1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11920-002-0026-5","volume":"4","author":"L. Degenhardt","year":"2002","unstructured":"Degenhardt L, Hall W. Cannabis and psychosis. Curr Psychiat Rep 2002, 4: 191\u2013196.","journal-title":"Curr Psychiat Rep"},{"key":"51_CR2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0920-9964(00)00132-8","volume":"48","author":"P.D. Skosnik","year":"2001","unstructured":"Skosnik PD, Spatz-Glenn L, Park S. Cannabis use is associated with schizotypy and attentional disinhibition. Schizophr Res 2001, 48: 83\u201392.","journal-title":"Schizophr Res"},{"key":"51_CR3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","volume":"58","author":"M.A. Huestis","year":"2001","unstructured":"Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, et al. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch Gen Psychiat 2001, 58: 322\u2013328.","journal-title":"Arch Gen Psychiat"},{"key":"51_CR4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.178.2.116","volume":"178","author":"A. Johns","year":"2001","unstructured":"Johns A: Psychiatric effects of cannabis. Brit J Psychiat 2001, 178: 116\u2013122.","journal-title":"Brit J Psychiat"},{"key":"51_CR5","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"W.A. Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946\u20131949.","journal-title":"Science"},{"key":"51_CR6","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","volume":"372","author":"V. Marzo Di","year":"1994","unstructured":"Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372:686\u2013691.","journal-title":"Nature"},{"key":"51_CR7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0091-3057(96)00426-1","volume":"56","author":"H.M. Emrich","year":"1997","unstructured":"Emrich HM, Leweke FM, Schneider U. Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav 1997, 56: 803\u2013807.","journal-title":"Pharmacol Biochem Behav"},{"key":"51_CR8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1254\/jphs.FMJ04003X4","volume":"96","author":"H. Ujike","year":"2004","unstructured":"Ujike H, Morita Y. New perspectives in the studies on endocannabinoid and cannabis: cannabinoid receptors and schizophrenia. J Pharmacol Sci 2004, 96: 376\u2013381.","journal-title":"J Pharmacol Sci"},{"key":"51_CR9","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","volume":"10","author":"F.M. Leweke","year":"1999","unstructured":"Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D. Elevated endogenous cannabinoids in schizophrenia. Neuroreport 1999, 10: 1665\u20131669.","journal-title":"Neuroreport"},{"key":"51_CR10","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1300558","volume":"29","author":"A. Giuffrida","year":"2004","unstructured":"Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkotter J, Piomelli D. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 2004, 29: 2108\u20132114.","journal-title":"Neuropsychopharmacology"},{"key":"51_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","volume":"103","author":"B. Dean","year":"2001","unstructured":"Dean B, Sundram S, Bradbury R, Scarr E, Copolov D. Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience 2001, 103: 9\u201315.","journal-title":"Neuroscience"},{"key":"51_CR12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","volume":"28","author":"K. Zavitsanou","year":"2004","unstructured":"Zavitsanou K, Garrick T, Huang XF. Selective antagonist [3H] SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiat 2004, 28: 355\u2013360.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiat"},{"key":"51_CR13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00221-006-0503-x","volume":"172","author":"K.A. Newell","year":"2006","unstructured":"Newell KA, Deng C, Huang XF. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp Brain Res 2006, 172: 556\u2013560.","journal-title":"Exp Brain Res"},{"key":"51_CR14","first-page":"173","volume":"60","author":"J.J. Kim","year":"2003","unstructured":"Kim JJ, Crespo-Facorro B, Andreasen NC, O\u2019Leary DS, Magnotta V, Nopoulos P. Morphology of the lateral superior temporal gyrus in neuroleptic naive patients with schizophrenia: relationship to symptoms. Schizophr Res 2003, 60: 173\u2013181.","journal-title":"Schizophr Res"},{"key":"51_CR15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","volume":"77","author":"M. Glass","year":"1997","unstructured":"Glass M, Dragunow M, Faull RL. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77: 299\u2013318.","journal-title":"Neuroscience"},{"key":"51_CR16","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1017\/S0033291700026337","volume":"23","author":"A. Jablensky","year":"1993","unstructured":"Jablensky A, Hugler H, Von Cranach M, Kalinov K. Kraepelin revisited: a reassessment and statistical analysis of dementia praecox and manic-depressive insanity in 1908. Psychol Med 1993, 23: 843\u2013858.","journal-title":"Psychol Med"},{"key":"51_CR17","first-page":"19","volume-title":"The Use of CNS Autopsy Tissue in Psychiatric Research: A Practical Guide","author":"N. Keks","year":"1988","unstructured":"Keks N, Hill C, Opeskin K, Copolov D, Dean B. Psychiatric diagnosis after death: the problems of accurate diagnosis. In: Dean B, Hyde TM, Kleinman J Ed. The Use of CNS Autopsy Tissue in Psychiatric Research: A Practical Guide. Sydney: Gordon & Breach Science Publishers, 1988, 19\u201337."},{"key":"51_CR18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pnpbp.2006.07.004","volume":"31","author":"K.A. Newell","year":"2007","unstructured":"Newell KA, Zavitsanou K, Jew SK, Huang XF. Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia. Prog Neuro psychopharmacol Biol Psychiatry 2007, 31: 225\u2013233.","journal-title":"Prog Neuro psychopharmacol Biol Psychiatry"},{"key":"51_CR19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0006-8993(93)90220-H","volume":"616","author":"A. Oviedo","year":"1993","unstructured":"Oviedo A, Glowa J, Herkenham M. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain Res 1993, 616: 293\u2013302.","journal-title":"Brain Res"},{"key":"51_CR20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0091-3057(94)90108-2","volume":"47","author":"F. Rodriguez de Fonseca","year":"1994","unstructured":"Rodriguez de Fonseca F, Gorriti MA, Fernandez-Ruiz JJ, Palomo T, Ramos JA. Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav 1994, 47: 33\u201340.","journal-title":"Pharmacol Biochem Behav"},{"key":"51_CR21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00210-005-1074-2","volume":"371","author":"S. Sundram","year":"2005","unstructured":"Sundram S, Copolov D, Dean B. Clozapine decreases [3H] CP55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens. Naunyn-Schmiedebergs Arch Pharmacol 2005, 371: 428\u2013433.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"51_CR22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/cercor\/bhg107","volume":"14","author":"C. Gaser","year":"2004","unstructured":"Gaser C, Nenadic I, Volz HP, Buchel C, Sauer H. Neuroanatomy of \u201chearing voices\u201d: a frontotemporal brain structural abnormality associated with auditory hallucinations in schizophrenia. Cereb Cortex 2004, 14: 91\u201396.","journal-title":"Cereb Cortex"},{"key":"51_CR23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/378176a0","volume":"378","author":"D.A. Silbersweig","year":"1995","unstructured":"Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L, Johnes T, Frackowiak RSJ. A functional neuroanatomy of hallucination in schizophrenia. Nature 1995. 378: 176\u2013179.","journal-title":"Nature"},{"key":"51_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0925-4927(00)00068-8","volume":"100","author":"B.R. Lennox","year":"2000","unstructured":"Lennox BR, Park SB, Medley I, Morris PG, Jones PB. The functional anatomy of auditory hallucinations in schizophrenia. Psychiat Res 2000, 100: 13\u201320.","journal-title":"Psychiat Res"},{"key":"51_CR25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(01)00104-4","volume":"107","author":"L.N. Voruganti","year":"2001","unstructured":"Voruganti LN, Slomka P, Zabel P, Mattar A, Awad AG. Cannabis induced dopamine release: an in-vivo SPECT study. Psychiat Res 2001, 107: 173\u2013177.","journal-title":"Psychiat Res"},{"key":"51_CR26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0301-0082(98)00087-2","volume":"58","author":"A. Ameri","year":"1999","unstructured":"Ameri A. The effects of cannabinoids on the brain. Prog Neurobiol 1999, 58: 315\u2013348.","journal-title":"Prog Neurobiol"},{"key":"51_CR27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1517\/14728222.10.2.203","volume":"10","author":"K.Y. Vinod","year":"2006","unstructured":"Vinod KY, Hungund BL. Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders. Expert Opin Ther Targets 2006,10: 203\u2013210.","journal-title":"Expert Opin Ther Targets"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-007-0051-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-007-0051-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-007-0051-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T06:51:32Z","timestamp":1559458292000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-007-0051-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1007\/s12264-007-0051-9","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}